Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 51, Issue 9, Pages 1081-1086
Publisher
Informa UK Limited
Online
2016-05-23
DOI
10.3109/00365521.2016.1157894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in Serum Trough Levels of Infliximab During Treatment Intensification but not in Anti-infliximab Antibody Detection are Associated with Clinical Outcomes after Therapeutic Failure in Crohn's Disease
- (2015) C. Steenholdt et al. Journal of Crohns & Colitis
- Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
- (2014) Y. Mazor et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment algorithms in Crohn's – Up, down or something else?
- (2014) Ophélie Antunes et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
- (2014) Stephane Paul et al. INFLAMMATORY BOWEL DISEASES
- Review article: immunogenicity of anti-TNF biologics in IBD - the role of patient, product and prescriber factors
- (2013) A. C. Moss et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease
- (2013) Sorcha O’Meara et al. INFLAMMATORY BOWEL DISEASES
- Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay
- (2013) Shui-Long Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Assessing Response and Loss of Response to Biological Therapies in IBD
- (2011) Henit Yanai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
- (2011) Hirotsugu Imaeda et al. JOURNAL OF GASTROENTEROLOGY
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
- (2009) Gert Van Assche et al. Journal of Crohns & Colitis
- Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease
- (2008) R. L. WEST et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started